Company
Ensem Therapeutics
Ensem Therapeutics has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ETX-929 dose escalation | Phase 1/2 | Metastatic Colorectal Cancer (CRC) |
Latest
No recent events.
Follow Ensem Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.